Claude Nicaise

Claude Nicaise founded Clinical Regulatory Services LLC in 2014, where he is working as Owner from 2014.
Dr. Nicaise also currently works at Filana Therapeutics, Inc., as Chairman from 2024, Sarepta Therapeutics, Inc., as Independent Director from 2015, Gain Therapeutics, Inc., as Independent Director from 2021, Chemomab Therapeutics Ltd., as Independent Director from 2021, Minoryx Therapeutics SL, as Independent Director from 2017, American Society of Clinical Oncology, Inc., as Member, American Society of Hematology, as Member, American Society for Microbiology, as Member, and European Society for Medical Oncology, as Member.
Dr. Nicaise also formerly worked at Bristol Myers Squibb Co., as Vice President-Global Development from 2004 to 2008, Alexion Pharmaceuticals, Inc., as Senior Vice President-Global Regulatory Affairs from 2008 to 2014, Ovid Therapeutics, Inc., as Head-Research & Development in 2023, Outlook Therapeutics, Inc., as Deputy Medical Officer, and Formula Pharmaceuticals, Inc., as VP-Clinical Development & Regulatory Affairs.
Dr. Nicaise received his doctorate degree from Université Libre de Bruxelles.